US doctors group sues FDA for limiting access to drug touted by Trump for COVID-19

Reuters|
A group of conservative U.S. doctors has sued the Food and Drug Administration for limiting use of the malaria drug hydroxychloroquine for COVID-19, arguing that the therapy should be made widely available to fight the pandemic.
The lawsuit represents the latest front in a highly politicized U.S. debate over access to hydroxychloroquine. The drug has been championed by President Donald Trump as a potential "game-changer" against the coronavirus, but its value has yet to be established. A clinical trial released on Wednesday found it to be ineffective in preventing infection.
Comments
The commenter agrees to the privacy policy of Ynet News and agrees not to submit comments that violate the terms of use, including incitement, libel and expressions that exceed the accepted norms of freedom of speech.
""